PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$0.77
-0.04 (-5.03%)
As of Nov 14, 2:47 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,129.6% upside
Low Target $25.28
Average Target $32.61
High Target $46.79
Current Price $0.77
Current
$0.77
Target
$32.61
$25.28 $32.61 avg $46.79
Scenario Analysis
Bear Case
$25.28
3,178.9%
Low target
Base Case
$32.61
+4,129.6%
Avg target
Bull Case
$46.79
+5,968.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.88
-59.0% from high
52-Week Low
$0.75
+2.8% from low
Target vs 52W High
$32.61
+1,634.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%